Page last updated: 2024-10-27

fluconazole and Hirschsprung Disease

fluconazole has been researched along with Hirschsprung Disease in 1 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Hirschsprung Disease: Congenital MEGACOLON resulting from the absence of ganglion cells (aganglionosis) in a distal segment of the LARGE INTESTINE. The aganglionic segment is permanently contracted thus causing dilatation proximal to it. In most cases, the aganglionic segment is within the RECTUM and SIGMOID COLON.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chong, PP1
Chieng, DC1
Low, LY1
Hafeez, A1
Shamsudin, MN1
Seow, HF1
Ng, KP1

Other Studies

1 other study available for fluconazole and Hirschsprung Disease

ArticleYear
Recurrent candidaemia in a neonate with Hirschsprung's disease: fluconazole resistance and genetic relatedness of eight Candida tropicalis isolates.
    Journal of medical microbiology, 2006, Volume: 55, Issue:Pt 4

    Topics: Antifungal Agents; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia;

2006